Shiprock Capital announces new Senior Sovereign Strategist
Mauro has had a distinguished career at institutions such as TCW Group, Goldman Sachs, the International Monetary Fund, the Federal Reserve Bank of New York and the Central Bank of Argentina.
At TCW Group, he was Head of Latin America Sovereign Strategy. At Goldman Sachs he was Senior Economist, Emerging Markets, and Chief Economist for Argentina, Venezuela and Ecuador.
He holds a PhD and a M.Phil in Economics from Columbia University.
Frederick Schroder, CEO at Shiprock, said, 'Mauro is a leading authority on Emerging Market sovereigns. He has had an extraordinary career so far and we are absolutely delighted to welcome him to Shiprock, where he will play a leading role in the investment team. This appointment demonstrates our continued focus on building the best-in-class talent base.'
Mauro Roca, Senior Sovereign Strategist at Shiprock, added, 'I have got to know Shiprock's team very well over the years and I am very glad to now be able to join them. I am joining an extremely talented firm that has been dynamic in its growth and in executing its investment strategy since inception.'
About Shiprock:
Shiprock Capital Management is an investment management firm focused on Global Distressed and Special Situations. Founded at the beginning of 2023, the firm manages assets in excess of $1bn and is London based.
Contact:
[email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
B2Gold Increases Position in Founders Metals
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or the "Company") announces that B2Gold Corp. ("B2Gold") has completed its obligations under the Shareholder Agreement by purchasing 1,170,000 common shares (the "Shares"), as outlined in the Company's November 5, 2024 press release. B2Gold purchased the Shares in the open market to fulfill its agreement and preserve its right to participate in future financings up to a maximum of 9.9% ownership. Together with its prior private placement subscriptions, B2Gold now holds ~6% of Founders' issued and outstanding common shares on a non-diluted basis. Colin Padget, President and CEO, commented: "B2Gold's decision to increase their position demonstrates strong confidence in Founders and the Antino Gold Project. Their continued investment reinforces our shared belief in Antino as a Tier 1 discovery, and we're pleased to have their ongoing support as we work to unlock the project's full potential and realize value for shareholders." About Founders Metals Inc. Founders Metals is a Canadian-based exploration company focused on advancing the Antino Gold Project located in Suriname, South America, in the heart of the Guiana Shield. Antino is 20,000 hectares and has produced over 500,000 ounces of gold from historical surface and alluvial mining to date1. The Company is systematically advancing one of Suriname's most promising gold exploration and development opportunities with drill-confirmed, district-scale potential. Founders is committed to responsible exploration, community engagement, and delivering long-term value to shareholders through technical excellence and strategic growth in the Guiana Shield. ON BEHALF OF THE BOARD OF DIRECTORS, Per: "Colin Padget" Colin PadgetPresident, Chief Executive Officer, and Director Contact Information Katie MacKenzie, Vice President, Corporate DevelopmentTel: 306 537 8903 | katiem@ Harp Gosal, Director, Investor RelationsTel: 236 301 4211 | harpg@ Cautionary Statement Regarding Forward-Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation, including statements regarding the use of proceeds from the Company's recently completed financings and the Company's prospects. Forward-looking information can generally be identified by words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes", or variations indicating that certain actions, events or results "may", "could", "would", "might" or "will" occur or be achieved. Forward-looking statements are based on management's current expectations and reasonable assumptions but are subject to business, market, and economic risks, uncertainties, and contingencies that may cause actual results to differ materially from those expressed or implied, including: general business and economic uncertainties; exploration results; mining industry risks; and other factors described in the Company's most recent annual management discussion and analysis. Although the Company has attempted to identify important factors that could cause actual results to differ materially, other factors may cause results not to be as anticipated. There can be no assurance that forward-looking information will prove accurate, as actual results and future events could differ materially from those anticipated. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information except in accordance with applicable securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. All material information on Founders Metals can be found at 12022 Technical Report - Antino Project; Suriname, South America. K. Raffle, BSc, P. Geo & Rock Lefrançois, BSc, To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 minutes ago
- Yahoo
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
The Investment is part of BrainsWay's ongoing strategy to acquire minority positions in leading U.S. mental health providers to help them raise awareness for and expand access to transformative care BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ('BrainsWay' or the 'Company'), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has entered into a strategic equity financing agreement with Axis Management Company, Inc. ('Axis Integrated Mental Health' or 'Axis'), a management services organization servicing several mental health clinics in Colorado. Under the terms of the agreement, BrainsWay will invest $2.3 million initially, and an additional potential $1 million milestone-based investment, for a minority position in Axis in the form of a preferred, annually compounding security. The agreement also provides for a redemption mechanism relating to the shares. 'Our minority-stake investment in Axis follows our previous investment in Stella, and is part of BrainsWay's broader initiative to accelerate access to and awareness of innovative mental health treatments, including Deep TMS Therapy, while continuing to maintain our core focus on advancing our scientific and technological capabilities to ensure best-in-class support for all our customers. Within this strategy, our investments provide capital injections into high performing healthcare providers, which then allows these businesses to invest in growth drivers and launch new locations,' said Hadar Levy, Chief Executive Officer of BrainsWay. 'We see tremendous opportunities for these healthcare providers to offer expanded services and grow their businesses once they secure the necessary capital.' 'Axis offers a robust clinical services platform and is committed to achieving rapid growth and excellent patient outcomes. We are thrilled to support and collaborate with them as their business continues to scale from a well-respected regional platform to one with a larger footprint, enhancing their delivery of life-changing care to additional patients,' concluded Mr. Levy. 'Our partnership with BrainsWay was born out of a mutual desire to deliver the best cutting-edge mental health treatments to the communities we serve,' stated Chris Perez, Chief Executive Officer of Axis. 'Given the peerless reputation of BrainsWay and its proprietary Deep TMS technology, we realize the value this strategic partnership will provide as we further advance in our mission of putting patients first through our best-in-class support.' About BrainsWay BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in the United States and Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit About Axis Axis Integrated Mental Health services its leading mental health practices, which are dedicated to transforming lives through a truly comprehensive, integrative model of care. With a team of board-certified specialists combining modern psychiatry and psychotherapy with advanced treatments including Deep TMS™ and Spravato®, Axis utilizes an evidence-based, holistic therapeutic approach to treat patients, all through a single, coordinated care experience under one roof. For more information, please visit Forward-Looking Statement This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words 'intends,' 'may,' 'will,' 'plans,' 'expects,' 'anticipates,' 'projects,' 'predicts,' 'estimates,' 'aims,' 'believes,' 'hopes,' 'potential' or similar words, and also includes any financial guidance and projections contained herein. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In addition, historical results or conclusions from scientific research and clinical studies do not guarantee that future results would suggest similar conclusions or that historical results referred to herein would be interpreted similarly in light of additional research or otherwise. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the failure of our investments in management services organizations and/or other clinic-related entities to produce profitable returns; inadequacy of financial resources to meet future capital requirements; changes in technology and market requirements; delays or obstacles in launching and/or successfully completing planned studies and clinical trials; failure to obtain approvals by regulatory agencies on the Company's anticipated timeframe, or at all; inability to retain or attract key employees whose knowledge is essential to the development of Deep TMS products; unforeseen difficulties with Deep TMS products and processes, and/or inability to develop necessary enhancements; unexpected costs related to Deep TMS products; failure to obtain and maintain adequate protection of the Company's intellectual property, including intellectual property licensed to the Company; the potential for product liability; changes in legislation and applicable rules and regulations; unfavorable market perception and acceptance of Deep TMS technology; inadequate or delays in reimbursement from third-party payers, including insurance companies and Medicare; inability to commercialize Deep TMS, including internationally, by the Company or through third-party distributors; product development by competitors; inability to timely develop and introduce new technologies, products and applications, which could cause the actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements. Any forward-looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading 'Risk Factors' in the Company's filings with the U.S. Securities and Exchange Commission. Contacts: BrainsWay:Ido MaromChief Financial Investors:Brian RitchieLifeSci Advisors LLCbritchie@ in to access your portfolio
Yahoo
2 minutes ago
- Yahoo
HMRC expects 42% of taxpayers to comply with MTD for income tax
UK's His Majesty's Revenue and Customs (HMRC) expects that 2,916,000 (42%) will need to comply with Making Tax Digital (MTD) for income tax of the 7,020,000 taxpayers with income from self-employment or property, that were within income tax self assessment (ITSA) for 2023/24. The Institute of Chartered Accountants in England and Wales (ICAEW) Tax Faculty has assessed the latest figures released by HMRC regarding MTD for income tax, detailing the implications for taxpayers, agents, and HMRC. HMRC has updated its estimates concerning the number of taxpayers expected to comply with MTD for income tax, based on income tax self-assessment (ITSA) returns for the 2023/24 tax year, which will be collected until 31 March 2025. The data categorises taxpayers by various characteristics, including agent representation, and is subject to rounding. The 2023/24 tax year is noted as a transitional period in the shift from basis periods to a tax year basis, which may have resulted in increased trade income for some taxpayers. The final number of taxpayers required to comply with MTD will depend on the information available for the relevant tax year. Taxpayers within the scope of MTD for income tax will be required to use software for maintaining accounting records and for submitting quarterly updates and an end-of-year tax return to HMRC. Compliance is mandatory only for those with total gross income from self-employment and property exceeding £20,000. The implementation timeline is as follows: April 2026 for those with total gross income over £50,000 in 2024/25; April 2027 for those exceeding £30,000 in 2025/26; and April 2028 for those surpassing £20,000 in 2026/27. Taxpayers not within the MTD scope may choose to volunteer for it. According to HMRC's data, 864,000 (30%) are expected to comply from April 2026, 1,077,000 (37%) from April 2027, and 975,000 (33%) from April 2028. This figure updates HMRC's previous estimate of 2,700,000 taxpayers. According to HMRC, 2,353,000 (81%) of those expected to be subject to MTD for income tax are self-employed, including 313,000 who also earn income from property. Of the 563,000 in-scope taxpayers who are landlords without self-employment income, 47% (263,000) are projected to join in April 2028, indicating a slower integration for landlords compared to self-employed individuals. While a majority of in-scope taxpayers are represented by an agent (1,900,000; 65%), a significant portion (1,018,000; 35%) are unrepresented. Additionally, most unrepresented in-scope taxpayers do not use commercial software for filing their tax returns (840,000; 83%). It remains uncertain how many of those using software for filing also utilise it for record-keeping. These statistics highlight the challenges HMRC faces in informing taxpayers about the upcoming changes and in providing necessary support for the transition to software-based record-keeping and filing. This is particularly urgent for the 217,000 unrepresented taxpayers who must comply with MTD for income tax starting in April 2026, which is now just over seven months away. The figures also present challenges for agents, as 527,000 (28%) of taxpayers in scope of MTD for income tax and represented by an agent did not submit their 2023/24 ITSA tax return using software. In February 2025, HMRC reported that 12,026,540 tax returns were submitted for the 2023/24 tax year. This indicates that approximately 9,110,540 taxpayers (76%) will not be required to adopt MTD for income tax, including 4,103,000 with self-employment and/or property income, and it is essential that the needs of these taxpayers are not overlooked amid the focus on MTD for income tax. "HMRC expects 42% of taxpayers to comply with MTD for income tax" was originally created and published by The Accountant, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
